These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6935082)

  • 21. Some new 5-substituted benzylidene-1-phenyl-3-(2'-pyridinobutan-4'-yl) thiobarbituric acids as psychopharmacological agents.
    Srivastava VK; Satsangi RK; Shankar K; Kishor K
    Pharmazie; 1981 Apr; 36(4):252-3. PubMed ID: 7255525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and preliminary screening of novel tryptamines as 5-HT4 receptor ligands.
    Hanna-Elias A; Manallack DT; Berque-Bestel I; Irving HR; Coupar IM; Iskander MN
    Curr Med Chem; 2010; 17(25):2775-87. PubMed ID: 20586717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New indolyl MAO inhibitors. Part 2.
    Sathi G; Gujrati VR; Nath C; Bhargava KP; Shanker K
    Pharmazie; 1982 Dec; 37(12):868-9. PubMed ID: 7163376
    [No Abstract]   [Full Text] [Related]  

  • 25. Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS.
    Brandt SD; Freeman S; Fleet IA; McGagh P; Alder JF
    Analyst; 2004 Nov; 129(11):1047-57. PubMed ID: 15508033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
    Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some problems concerning the apparent multiplicity of monoamine oxidase [proceedings].
    Tipton KF; Mantle TJ; Houslay MD
    Psychopharmacol Bull; 1977 Jan; 13(1):46-7. PubMed ID: 834820
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis and selective monoamine oxidase B-inhibiting properties of 1-methyl-1,2,3,6-tetrahydropyrid-4-yl carbamate derivatives: potential prodrugs of (R)- and (S)-nordeprenyl.
    Flaherty P; Castagnoli K; Wang YX; Castagnoli N
    J Med Chem; 1996 Nov; 39(24):4756-61. PubMed ID: 8941389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1-N-substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: synthesis and evaluation as MAO inhibitors.
    Gökhan N; Yeşilada A; Uçar G; Erol K; Bilgin AA
    Arch Pharm (Weinheim); 2003 Aug; 336(8):362-71. PubMed ID: 14502756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. THE EFFECT OF DIETHYLTRYPTAMINE AND ITS DERIVATIVES ON MONOAMINE OXIDASE.
    HUSZTI Z; BORSY J
    Biochem Pharmacol; 1964 Aug; 13():1151-6. PubMed ID: 14222512
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis of azetidines.
    Wells JN; Tarwater OR
    J Pharm Sci; 1971 Jan; 60(1):156-7. PubMed ID: 5548233
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives.
    Palaska E; Aydin F; Uçar G; Erol D
    Arch Pharm (Weinheim); 2008 Apr; 341(4):209-15. PubMed ID: 18266289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Carcinogenic action of 5-methoxytryptamine related to its transformation into 5-methoxyindolyl-3-acetic acid].
    Sergeeva TI; Romanenko VI; Raushenbakh MO; Andreeva NI
    Eksp Onkol; 1985; 7(4):26-9. PubMed ID: 2412783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship between chemical structure and pharmacologic activity of several new monoamine oxidase inhibitors].
    Boissier JR; Dumont C; Forest J
    Therapie; 1967; 22(2):367-73. PubMed ID: 6063424
    [No Abstract]   [Full Text] [Related]  

  • 35. Some preliminary data about the properties of tribulin, an endogenous, benzodiazepine receptor binding inhibiting compound from human urine.
    Flechsenhar K; Müller WE
    Pharmacopsychiatry; 1988 Nov; 21(6):357-9. PubMed ID: 2854276
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis of N-cinchonyl-N'-isopropyl (or aralkyl) hydrazines structurally related to MAO inhibitors.
    Roushdi IM; Ibrahim el-SA ; Farghaly AM; el-Khawass SM
    Pharmazie; 1973 May; 28(5):297-300. PubMed ID: 4715045
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of monoamine oxidase B by N-methyl-2-phenylmaleimides.
    Manley-King CI; Terre'Blanche G; Castagnoli N; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2009 Apr; 17(8):3104-10. PubMed ID: 19324554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins.
    Chimenti F; Secci D; Bolasco A; Chimenti P; Bizzarri B; Granese A; Carradori S; Yáñez M; Orallo F; Ortuso F; Alcaro S
    J Med Chem; 2009 Apr; 52(7):1935-42. PubMed ID: 19267475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1,3,4-Oxadiazole-3(2H)-carboxamide derivatives as potential novel class of monoamine oxidase (MAO) inhibitors: synthesis, evaluation, and role of urea moiety.
    Ke S; Li Z; Qian X
    Bioorg Med Chem; 2008 Aug; 16(16):7565-72. PubMed ID: 18678501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F
    J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.